ARCT icon

Arcturus Therapeutics
ARCT

Overview Fund Activity

23 hedge funds and large institutions have $17.7M invested in Arcturus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
5
Closed
4
Calls
$381K
Puts
$147K
Net Calls
+$234K
Net Calls Change
+$152K

Top Buyers

1
HCM
1
Highline Capital Management
New York
$2.06M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$1.23M
3
AIM
3
ARK Investment Management
Florida
$9.48M
4
NAMA
4
Nikko Asset Management Americas
New York
$1.23M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$388K

Top Sellers

1
DCM
1
DAFNA Capital Management
California
$23K
2
Morgan Stanley
2
Morgan Stanley
New York
$408K
3
DC
3
Diametric Capital
Massachusetts
$361K
4
PCM
4
Prelude Capital Management
New York
$165K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
– – -84 Closed
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
TRCT
28
Tower Research Capital (TRC)
New York
$0 52 +52 New
1
2